| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | — | — | — | — | — | — | 3 | — | — | — |
| Sell | — | — | 1 | — | — | — | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡ |
|
| 2026 | 0.04 |
—
—
—
|
| 2025 | 0.04 |
—
—
—
—
|
| 2024 | 0.04 |
—
—
—
—
|
| 2023 | 0.04 |
—
—
—
—
|
| 2022 | 0.05 |
—
—
—
—
—
|
| 2021 | 0.04 |
—
—
—
—
|
| 2020 | 0.04 |
—
—
—
—
|
| 2019 | 1.52 |
—
—
—
—
|
| 2018 | 1.52 |
—
—
—
—
—
|
| 2017 | 1.52 |
—
—
—
—
|
| 2016 | 1.52 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 193.64 | 217.59 | 196.20 | 270.41 |
| Receivables | 43.91 | 39.13 | 34.18 | 44.29 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 237.55 | 256.72 | 230.39 | 314.70 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 238.64 | 222.23 | 199.63 | 221.66 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 245.47 | 233.78 | 211.74 | 234.63 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 345.66 | 407.14 | — | — |
—
|
| ’25 | 320.27 | 407.54 | 398.72 | 349.02 |
1,475.54
|
| ’24 | 314.07 | 397.11 | 404.53 | 337.60 |
1,453.31
|
| ’23 | 305.72 | 384.34 | 395.80 | 334.09 |
1,419.95
|
| ’22 | 258.07 | 397.52 | 416.69 | 319.61 |
1,391.89
|
| ’21 | 83.64 | 163.31 | 238.81 | 247.28 |
733.04
|
| ’20 | 269.11 | 22.59 | 76.98 | 74.21 |
442.89
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 84.05 | 86.32 | — | — |
—
|
| ’25 | 50.34 | 90.54 | 77.57 | 31.28 |
249.73
|
| ’24 | 46.00 | 83.67 | 76.08 | 69.25 |
275.00
|
| ’23 | 46.23 | 73.99 | 82.06 | 33.91 |
236.20
|
| ’22 | 38.83 | 103.80 | 111.78 | 24.33 |
278.75
|
| ’21 | (7.14) | 4.85 | 46.54 | 26.51 |
70.77
|
| ’20 | 1.49 | (88.07) | (60.28) | (54.92) |
(201.78)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 72.11 | 89.95 | — | — |
—
|
| ’25 | 29.68 | 61.69 | 56.33 | 107.26 |
254.97
|
| ’24 | (3.48) | 50.48 | 57.89 | 41.36 |
146.25
|
| ’23 | 143.60 | 103.34 | 39.68 | 63.89 |
350.50
|
| ’22 | 18.93 | 154.26 | 261.87 | (24.14) |
410.91
|
| ’21 | (16.76) | 142.33 | 120.81 | (3.52) |
242.87
|
| ’20 | 271.43 | (127.61) | (25.99) | (69.49) |
48.34
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.26) | 0.17 | — | — |
—
|
| ’25 | (0.37) | 0.06 | (0.37) | (0.23) |
(0.90)
|
| ’24 | (0.32) | 0.16 | 0.24 | (0.51) |
(0.39)
|
| ’23 | (0.27) | 0.24 | (0.57) | (0.37) |
(0.93)
|
| ’22 | (0.85) | 0.12 | 0.10 | (0.34) |
(0.95)
|
| ’21 | (0.98) | (0.07) | (0.34) | (0.41) |
(1.80)
|
| ’20 | 0.26 | (1.06) | (1.06) | (1.39) |
(3.25)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 12.54 | 11.39 | 11.65 | 7.41 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.14 | 17.38 | 16.65 | 14.21 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 58 | 60 | 60 | 52 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.00 | 23.67 | 24.22 | 28.38 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,391.89 | 1,419.95 | 1,453.31 | 1,475.54 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.47% | 24.95% | 25.19% | 24.17% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (84.70) | (73.62) | (25.61) | (55.94) | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.09%) | (5.18%) | (1.76%) | (3.79%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (84.98) | (74.28) | 0.02 | (62.23) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 253.04 | 252.77 | 243.86 | 240.17 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.67 | 11.66 | 12.13 | 12.61 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | (0.95) | (0.93) | (0.39) | (0.90) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.14 | 1.94 | 2.30 | 2.13 | ‡‡‡‡ | ‡‡‡‡‡ | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.01 | 0.94 | (1.07) | 0.04 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.15 | 2.88 | 1.22 | 2.18 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.64 | 23.40 | 23.28 | 21.90 | ‡‡‡‡‡ | ‡‡‡‡ | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 130.45 | 121.81 | 119.78 | 117.03 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.21 | 1.36 | 1.12 | 0.90 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.54 | 0.68 | 0.58 | 0.52 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.21 | 2.89 | 2.55 | 2.24 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.89 | 11.71 | 25.30 | 12.95 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 278.75 | 236.20 | 275.00 | 249.73 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 132.17 | 114.31 | (128.75) | 5.24 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 410.91 | 350.50 | 146.25 | 254.97 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (157.53) | (7.92) | 22.94 | 18.65 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,849.29 | 2,319.80 | 2,246.73 | 2,124.09 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,797.02 | 2,126.16 | 2,029.14 | 1,927.89 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,084.54 | 2,850.35 | 2,787.87 | 2,562.74 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.00%) | (1.89%) | (0.81%) | (1.92%) | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.16% | 0.47% | 1.09% | 0.61% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.97%) | (3.82%) | (1.66%) | (3.95%) | ‡‡‡‡‡ | — | — |
ROE
|
Pebblebrook Hotel Trust (PEB), a REIT specializing in upscale and luxury hotels in key U.S. urban and resort markets, is navigating post-COVID recovery with stabilizing revenues around $1.45 billion but persistent profitability hurdles, trading at depressed levels that reflect investor caution. Pre-pandemic growth saw revenues double from $816 million in 2016 to $1.61 billion in 2019, driven by acquisitions and strong RevPAR, only for 2020 lockdowns to slash them 73% amid negative margins and a stock plunge to $5 lows. Partial rebounds have restored per-share metrics toward pre-COVID norms via buybacks and asset sales, yet net income remains razor-thin, with ROE negative and book value down 16%.
Balance sheet deleveraging—from $2.85 billion peak debt to $2.25 billion—has improved EV/Sales to a cheap 2.5x, aided by $500 million in dispositions post-2018 merger, though interest coverage lags in a high-rate world. Bullish insider activity stands out: zero net sells since March 2025, with the CEO and directors buying over $2.5 million in shares near $9-12 lows, signaling confidence in an inflection point. Analyst forecasts show flat revenues through 2027 but narrowing losses (EPS improving 58%) and FCF growth to $2.87/share, implying dividend potential.
At PS ratios near 1.1x (versus historical 2.5x) and EV/FCF at 25x, PEB offers turnaround appeal with 20-30% upside if travel demand accelerates, mirroring 2015-2019 CAGRs. Risks include margin squeezes from OPEX and urban slumps, but correlations between insider buys, FCF troughs, and revenue uptrends suggest outperformance ahead—explore the full analysis for detailed forecasts and correlations.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.